Samyang Genex to gear up for supply of docetaxel to generic drugmakers

Published: 2009-09-15 06:57:00

Updated: 2009-09-15 06:57:00

Samyang Geex has unveiled its plan to manufacture the first industrial-scale current good manufacturing practice (cGMP) batch of its key intermediate for docetaxel, the active pharmaceutical ingredient (API) of Sanofi-Aventis's blockbuster chemotherapy drug Taxotere, whose patents will expire at ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK